Offering Alltest Covid 19 antigen + A+B flue, 1:3 combo tests, single packed, self testing, 2 years self time from my warehouse in Vilnius, Lithuania. Good price from authorised Alltest distributor.
Covid-19 or commonly known as Coronavirus is a viral infection involving a patients upper respiratory tract. It is highly contagious and causes a severe lung infection which can be severely debilitating and sometimes fatal. Our test detects two types of antibodies to Covid-19 which appear from 2 to 21 days after infection. It is an invaluable test to diagnose people who have been sick for a few days or those who have recovered.
Salient Features of the Product
It is rapid immunoassay for qualitative detection of Covid-19 IgM and IgG antibodiesin
We hope everyone is doing their best to "be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using alcohol-based rub frequently and not touching your face." -WHO
Affordable at-home COVID-19 testing. Results within minutes.
A Leading POCT and IVD Enterprise In China!
Attached to the Chinese Academy of Sciences!
Quality Comes From Professionalism And Service Makes The Future
We have a complete international after-sales processing system and provides 24 hours service.
Any more questions please contact me!
Covid-19 Antigen Rapid Test Kit (Colloidal gold)
Covid-19 IgM/IgG Test Kit (Colloidal gold)
Covid-19 IgM/IgG Test Kit (Rare earth nano fluorescence immunochromatography)
ISO13485 certified
Samples are available
At-home testing
Results within 15mins
Accurate
Simple
Rapid
Authorities approved
Monthly productivity 15 million units
Product Features
Easy Shorten window period in Antigen detection
Flexible Saliva sample, Nasal/Throat swabs sample, VTM
Simple Visual result interpreted, no instrument required
Rapid Result interpreted in 15 minutes
Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following:
General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients.
Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels.
Epidemiological COVID-19 surveys at national and district levels for research purposes.
Airport screening for arriving /departing passengers to control the pandemic in the aviation industry.
Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures.
Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies.
Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.
Intended use:
AIVD COVID-19(SARS-CoV-2) IgG/IgM Rapid Test is a single use, rapid device for qualitative detection of total antibodies against 2019 novel coronavirus (SARS-CoV-2) in human serum, plasma or whole blood specimens. The kit is intended for screening of patients suspected for infection with SARS-CoV-2, and as an aid in the diagnosis of the coronavirus disease 2019 (COVID-19).
Descriptionï¼?
Novel coronavirus pneumonia (NCP) or SARS-COV-2, that was officially named by the WHO as â??Corona virus disease 2019â?? (COVID-19), is a respiratory infection caused by a new virus that was first identified in late 2019.
IgM/IgG Rapid Kit can specifically detect IgM and IgG antibodies of COVID-19, covering the entire course of infection and recovery period of patients. This approach improves the overall diagnosis of COVID-19 in both acute and recovery phases of illness.
This kit utilizes the principle of colloidal gold immunochromatography to qualitatively detect the new coronavirus (COVID-19) IgG / IgM antibodies in human serum and plasma. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of COVID-19 suspected patients.
This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well, and then add the required amount of a diluent. The IgG / IgM antibodies in the sample will interact with the colloidal gold-labeled COVID-19 recombinant antigen on the conjugate pad. Then the conjugate pad will release re-solubilized conjugate onto the nitrocellulose membrane. The nitrocellulose membrane (NC membrane) diffuses it forward.
As the sample moves along the device binding reagents situated on the nitrocellulose membrane bind to the target at the test line. If the sample contains a COVID-19 IgG antibodies, they will bind to the colloidal gold-labeled novel coronavirus recombinant antigen, diffuse forward, and then react with the anti-human IgG antibodies immobilized on the NC membrane detection line (T2 line). Similarly, if the specimen contains IgM antibodies to COVID-19, the antibodies will react with antigen-coated particles, the conjugate migrate laterally forward, and cause a colored line (T1 line). The darker the color of colloidal gold on the test line, the higher the concentration antibodies to COVID-19 in the sample.
Accuracy:ï¼?> 90%
Specificity: 97%
Basic Protocolï¼?
1. Remove the test specimen, required reagents from storage conditions, and equilibrate to room temperature.
2. Unpack the aluminum foil bag, place the test horizontally on the table and number it.
3. Add 10ul serum, plasma or whole blood sample to the sample well with a pipette or a dropper. Slowly add 2 drops of sample dilution (about 60uL) to the sample well.
4. Read the results within 10-15 minutes after adding the sample, and the results will be invalid after 30 minutes.
The accuracy of the rapid test is 93% for IgM detection and 98% for IgG detection, compared to the RT-PCR Tests done at individual labs in The Netherlands.
Pricing clears and depends on volumes naturally. Please ask the exact quote with the volume requested information.
CE and FDA EUA approved
Made in USA, Germany, Canada
In the past two months, China was infected by the COVID-19( Noval Coronavirus), in order to diagnose the diseases earlier, Encode team work hard and finally develop the COVID-19 IgM/IgG rapid test kit, which clinical positive detection rate is over 90%.
For in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasal (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days after onset of symptoms.
This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, not for at-home testing.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or 2019-nCoV) is an enveloped non-segmented positive-sense RNA virus. It is the cause of coronavirus disease (COVID-19), which is contagious in humans. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N).
The antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
Positive results do not rule out a bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Negative results should be treated as presumptive, which do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.
For in vitro diagnostic use only. For professional use only .
Cat No: RK056-20. STANDARD Q COVID-19 IgM/IgG Combois a rapid Immunochromatographic assay for the qualitative dtection of specific antibodies to SARS-CoV-2 present in human Serum,Plasma or Whole Blood specimen.
Rapid testing for detection of IgM & IgG antibodies against SARS CoV-2
10 µl of specimen: Serum, Plasma & Whole Blood
Long term storage of 24 months at 2 - 30 C
Complementary to RT-PCR Test
Can be performed without extra equipment
Our SARS-CoV-2 IgM/IgG Antibody Test Kits are single-use rapid immunochromatographic tests for the qualitative detection and differentiation of Immunoglobulin M(IgM) and Immunoglobulin G(IgG) antibodies to SARS-CoV-2 in human serum, plasma (heparin, dipotassium EDTA, and sodium citrate), and venous whole blood (heparin, dipotassium EDTA, and sodium citrate). They are intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Angiten-COVID-19 Virus Test Kit (Colloidal Gold)
Quantity of box: 25 persons/box
Brand: Easysweet
NMPA (National Medical Products Administration): Approved
CE: with CE mark
BfArM: listed
Test Method: Antigen Test
Result Time: 10-15 mins
Sample Type: Nasal Swab
Sensitivity: 96.70%
Specificity: 100%
Accuracy: 98.94%
Shelf Life: 24 months
Storage Temperature: 2-30 Degree Celsius
Country of Origin: Made in China
Additional Information:
Production Capacity: 1 million
Delivery Time: 10-15 days
Packaging Details: 25 tests in a pack, 40packs/ carton
Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.
Rapid 2019-nCoV IgG/IgM Combo Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. Rapid 2019-nCoV IgG/IgM Combo Test Card is a supplement detection for COVID-19 suspected infected patients besides nucleic acid test, which could greatly raise the accuracy of the detection for COVID-19.
25 tests/box, CE Mark and ISO, Clinical report, Certificate of analysis (COA)
Clinical specify >98.89%
Accuracy: 93.41%
Specimen: whole blood/serum, 10 minutes to get results
We are the authorized first vendor of ADTech!
KFDA CE approved,
FDA Pending
Price : Negotiable
Pre-Clinical Test Report
Accuracy
- In total samples 93.3% (14/15) - In positive samples 91.7% (11/12)
1. Pre-Clinical Test summary
1) Pre-clinical test is fulfilled by Domestic large clinical laboratory with ADTech COVID-19 IgM/IgG RAPID KIT
2) Tests are made by total 15 samples with 12 positive and 3 negative samples
3) Clinical Laboratory tested the sample with Immunofluorescence Analysis
2. Pre-clinical test result
1) Samples were tested by ADTech COVID-19 IgM/IgG RAPID KIT
2) Test result by ADTechs RAPID KIT
- 4 negatives and 11 positives results in 15 samples
3) Comparison between Immunofluorescence analysis and ADTechs RAPID KIT
- 14 test results are same(including negative and positive results) - 1 samples test result are different(Positive Negative by ADTech
SARS-CoV-19 IgG/IgM test kit (15min showing result)
Manufacturer: Guangzhou Wanfo Biotech Co., Ltd. a China listing company
Certificates: CE certificate, China NMPA approval (export allowed), no FDA approval
The price is $5.5/test (FOB)
Max delivered quantity: 100,000/weekly
More details please enquire Barry Liu whatsapp: +8617810331113
sample available: 20 test & DHL delivery: $200
Download introductions: https://kdocs.cn/l/sLLC9O6rc
4260 Covid 19 Igm Igg Antibody Test (Colloidal Gold) Suppliers
Short on time? Let Covid 19 Igm Igg Antibody Test (Colloidal Gold) sellers contact you.
